229 related articles for article (PubMed ID: 32881386)
21. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway.
Seo JH; Ahn Y; Lee SR; Yeol Yeo C; Chung Hur K
Mol Biol Cell; 2005 Jan; 16(1):348-57. PubMed ID: 15537704
[TBL] [Abstract][Full Text] [Related]
22. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
RodrÃguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
23. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis.
Saurus P; Tolvanen TA; Lindfors S; Kuusela S; Holthöfer H; Lehtonen E; Lehtonen S
Sci Rep; 2017 Sep; 7(1):10731. PubMed ID: 28878342
[TBL] [Abstract][Full Text] [Related]
25. Redox regulation of tumor suppressor PTEN in cancer and aging (Review).
Kitagishi Y; Matsuda S
Int J Mol Med; 2013 Mar; 31(3):511-5. PubMed ID: 23313933
[TBL] [Abstract][Full Text] [Related]
26. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
27. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids.
Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M
Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364
[TBL] [Abstract][Full Text] [Related]
28. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase.
Gupta A; Dey CS
Mol Cell Endocrinol; 2009 Oct; 309(1-2):55-62. PubMed ID: 19501627
[TBL] [Abstract][Full Text] [Related]
29. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
Fu X; Creighton CJ; Biswal NC; Kumar V; Shea M; Herrera S; Contreras A; Gutierrez C; Wang T; Nanda S; Giuliano M; Morrison G; Nardone A; Karlin KL; Westbrook TF; Heiser LM; Anur P; Spellman P; Guichard SM; Smith PD; Davies BR; Klinowska T; Lee AV; Mills GB; Rimawi MF; Hilsenbeck SG; Gray JW; Joshi A; Osborne CK; Schiff R
Breast Cancer Res; 2014 Sep; 16(5):430. PubMed ID: 25212826
[TBL] [Abstract][Full Text] [Related]
30. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
[TBL] [Abstract][Full Text] [Related]
31. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
32. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
33. Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma.
Tang T; Xiao ZY; Shan G; Lei HB
Biomed Pharmacother; 2019 Oct; 118():109392. PubMed ID: 31545285
[TBL] [Abstract][Full Text] [Related]
34. APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2.
DeKroon R; Robinette JB; Hjelmeland AB; Wiggins E; Blackwell M; Mihovilovic M; Fujii M; York J; Hart J; Kontos C; Rich J; Strittmatter WJ
Circ Res; 2006 Oct; 99(8):829-36. PubMed ID: 16973905
[TBL] [Abstract][Full Text] [Related]
35. Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway.
Kim JH; Lee G; Cho YL; Kim CK; Han S; Lee H; Choi JS; Choe J; Won MH; Kwon YG; Ha KS; Kim YM
Eur J Pharmacol; 2009 Jan; 602(2-3):422-31. PubMed ID: 19027002
[TBL] [Abstract][Full Text] [Related]
36. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
Sasaoka T; Wada T; Tsuneki H
Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
[TBL] [Abstract][Full Text] [Related]
37. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
38. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway.
Weng LP; Brown JL; Baker KM; Ostrowski MC; Eng C
Hum Mol Genet; 2002 Jul; 11(15):1687-96. PubMed ID: 12095911
[TBL] [Abstract][Full Text] [Related]
39. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
Zhuang G; Hunter S; Hwang Y; Chen J
J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
[TBL] [Abstract][Full Text] [Related]
40. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
